Ethyl 2-((2-methoxyphenyl)thio)-2-oxoacetate

Catalog No.: 
ACBVSY971
CAS No.: 
1443313-30-1
Molecular Formula: 
C11H12O4S
Molecular Weight: 
240.28
Ethyl 2-((2-methoxyphenyl)thio)-2-oxoacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$132.00InquiryInquiry
1g97%$411.00InquiryInquiry
5g97%$2034.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-((2-methoxyphenyl)thio)-2-oxoacetate
IUPAC Nameethyl 2-((2-methoxyphenyl)thio)-2-oxoacetate
Molecular FormulaC11H12O4S
Molecular Weight240.28
SMILESO=C(OCC)C(SC1=CC=CC=C1OC)=O
InChI KeyNGTGQDHXDMYNCB-UHFFFAOYSA-N
SynonymETHYL 2-((2-METHOXYPHENYL)THIO)-2-OXOACETATE;Acetic acid, 2-[(2-methoxyphenyl)thio]-2-oxo-, ethyl ester
CAS No.1443313-30-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBVSY971 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAERG142 route compound structure diagram
    ACAERG1427217-59-6In Stock
  4. Then
  5. ACBVSY971 route product structure diagram
    ACBVSY9711443313-30-1
Inquiry

2. ACBVSY971 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBVSY971 route product structure diagram
    ACBVSY9711443313-30-1
Inquiry

3. ACBVSY971 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBVSY971 route product structure diagram
    ACBVSY9711443313-30-1
Inquiry

Comments (0)